# DOMAINS — Stroke Pharmacology Taxonomy & Keyword Map

## 1. Stroke types & stages
- Ischemic stroke (AIS), transient ischemic attack (TIA)
- Intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH)
- Stages: hyperacute (0–6h), acute (6–72h), subacute (3–14d), chronic repair (>14d)

Keywords:
ischemic stroke, AIS, MCAO, reperfusion injury, penumbra
ICH, hematoma expansion, perihematomal edema
SAH, vasospasm, delayed cerebral ischemia

---

## 2. Therapeutic strategies (recommended top-level buckets)
### Reperfusion / adjunct
tPA, thrombectomy, no-reflow, microcirculation, reperfusion injury

### Neuroprotection (core)
excitotoxicity, NMDA/AMPA, calcium overload, spreading depolarization

### Anti-inflammatory / immune modulation
microglia, macrophage, NLRP3, TLR4, NF-κB, cytokines, neutrophils

### BBB protection / edema
tight junctions, MMP-9, AQP4, endothelial dysfunction, glycocalyx

### Oxidative stress / mitochondria
ROS, NADPH oxidase, Nrf2, mitophagy, mitochondrial permeability

### Cell death pathways
apoptosis, necroptosis, pyroptosis, ferroptosis, autophagy dysregulation

### Repair & regeneration
angiogenesis, neurogenesis, synaptic plasticity, axonal sprouting

---

## 3. Preclinical models (common)
- MCAO: transient/permanent (rat/mouse)
- Photothrombotic stroke
- Embolic clot models
- ICH models: collagenase, autologous blood injection
- In vitro: OGD/R, BV2 microglia stimulation, endothelial monolayers

---

## 4. Outcomes (what to extract)
### Preclinical
- Infarct volume (TTC / MRI)
- Neurological score (mNSS, Bederson, Garcia)
- Brain edema / water content
- BBB integrity (Evans blue, tight junction proteins)
- Inflammation markers (IL-1β, TNF-α, Iba1, GFAP)
- Survival / hemorrhagic transformation

### Clinical
- NIHSS, mRS (e.g., mRS 0–2)
- Mortality
- Symptomatic ICH (sICH)
- Imaging endpoints (optional): core/penumbra, edema, hemorrhagic transformation

---

## 5. Pharmacology-specific fields (must-have)
- Dose, route, frequency
- Time-to-treatment window
- PK/PD (if available)
- BBB penetration / brain concentration evidence
- Off-target & safety signals
- Interaction with reperfusion therapy (tPA/EVT)
